InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Talamo Joseph. Director active across 2 companies, notably Caladrius Biosciences, INC.. Aggregated, 4 filings have been recorded. History available since 30 June 2025. The latest transaction was filed on 31 December 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Talamo Joseph has 4 filings in total. The sampled filings cover the period from 2016-01-27 to 2026-01-05 and, for these recent filings, the stated buy amount is 0 and the stated sell amount is 0; the listed transaction nature is Attribution. He is Chief Financial Officer at INTENSITY THERAPEUTICS, INC. and See Remarks at Caladrius Biosciences, INC.